Send us Feedback

Genenews LTD (GEN)
Analysis
SUMMARY
BULLS
BEARS
Data
DATA CENTRAL
STOCK CHART
Financials
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
GeneNews Diagnostics Launches ColonSentry in Malaysia
Marketwire  Nov 9  Comment 
TORONTO, ONTARIO -- (Marketwire) -- 11/09/11 -- GeneNews Limited (TSX:GEN), a molecular diagnostics company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced the
GeneNews Announces SentinelGx(TM) Pharmacogenomic and Companion Diagnostic BloodRNA(TM) Services
Marketwire  Oct 28  Comment 
TORONTO, ONTARIO -- (Marketwire) -- 10/28/11 -- GeneNews Limited (TSX:GEN), a molecular diagnostics company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced the
GeneNews' Sentinel Principle(R) Used to Discover New Blood Based Biomarkers for Schizophrenia
Marketwire  Oct 12  Comment 
TORONTO, ONTARIO -- (Marketwire) -- 10/12/11 -- GeneNews Limited (TSX:GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced the publication of study
New Study Demonstrates Value of ColonSentry(TM) as Pre-Screening Alert to Enhance Effectiveness of Colorectal Cancer Screening
Marketwire  Aug 24  Comment 
TORONTO, ONTARIO -- (Marketwire) -- 08/24/10 -- GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, announced that a poster describing a
GeneNews Reports Second Quarter 2010 Financial Results
Marketwire  Aug 11  Comment 
TORONTO, ONTARIO -- (Marketwire) -- 08/11/10 -- GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today reported operational and financial
GeneNews Executes Marketing Partnership Agreement with GeneDiagnostics
Marketwire  Jun 30  Comment 
TORONTO, ONTARIO -- (Marketwire) -- 06/30/10 -- GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has executed a
Malaysian Study Further Validates GeneNews' ColonSentry(TM) Test
Marketwire  Jun 3  Comment 
TORONTO, ONTARIO -- (Marketwire) -- 06/03/10 -- GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, announced that an abstract describing a
GeneNews Partners with GeneDiagnostics Inc. to Market ColonSentry(TM) in China
Marketwire  May 19  Comment 
TORONTO, ONTARIO -- (Marketwire) -- 05/19/10 -- GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has executed a
GeneNews Issued U.S. Patents for Schizophrenia and Osteoarthritis Based on Core Sentinel Principle(R) Platform
Marketwire  May 11  Comment 
TORONTO, ONTARIO -- (Marketwire) -- 05/11/10 -- GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has been granted
GeneNews to Feature ColonSentry(TM) at the 8th Annual Primary Care Today Conference
Marketwire  May 5  Comment 
TORONTO, ONTARIO -- (Marketwire) -- 05/05/10 -- GeneNews Limited (TSX: GEN), an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management, today announced




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 




References

Retrieved from "http://www.wikinvest.com/stock/Genenews_LTD_(GEN)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki